iifl-logo

Gland Pharma Ltd Historical Data

1,905.8
(0.07%)
Oct 30, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gland Pharma Ltd Historical Data

30/09/2025calendar-icon
30/10/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

30-Sep-2025

2,003.3

2,040.91,978.11,991.623,01638,92,06,422.81,29,958

01-Oct-2025

1,992

2,026.11,9741,981.616,56919,37,65,931.750,212

03-Oct-2025

1,960.1

2,0001,9451,951.417,21427,29,69,725.377,851

06-Oct-2025

1,953

1,957.51,9261,939.611,47326,00,75,975.290,306

07-Oct-2025

1,940.5

1,9501,924.31,940.38,7419,01,16,669.624,226

08-Oct-2025

1,937.8

1,964.91,9251,9578,79414,05,79,130.340,903

09-Oct-2025

1,955

1,969.61,937.11,952.814,36934,05,60,073.71,37,188

10-Oct-2025

1,951

1,9531,915.91,923.414,92123,54,64,187.884,338

13-Oct-2025

1,924

1,9401,913.41,928.67,7797,18,63,938.314,756

14-Oct-2025

1,925

1,946.91,903.61,920.815,38925,27,42,235.672,036

15-Oct-2025

1,910.1

1,9451,9061,936.57,96310,77,80,925.227,078

16-Oct-2025

1,924

1,943.91,906.21,917.610,01819,65,39,505.272,432

17-Oct-2025

1,923.6

1,950.31,911.81,937.88,5649,98,22,333.726,886

20-Oct-2025

1,931.2

1,9361,908.61,924.87,41213,53,42,11749,154

21-Oct-2025

1,937.8

1,937.81,9181,922.58881,44,18,502.34,420

23-Oct-2025

1,937.9

1,9631,917.41,932.110,35715,77,10,227.839,206

24-Oct-2025

1,925

1,9551,9251,941.48,45010,36,87,665.925,039

27-Oct-2025

1,941.4

1,967.91,892.41,918.114,18428,78,83,598.680,148

28-Oct-2025

1,925

1,927.51,8891,902.411,19622,08,79,309.879,847

29-Oct-2025

1,910

1,9201,9021,904.59,54512,43,73,652.243,553

Gland Pharma: Related NEWS

Top Stocks for Today - 14th July 2025

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

14 Jul 2025|06:30 AM
Read More
Gland Pharma Gets USFDA Clearance for Visakhapatnam Facility

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

25 Jun 2025|12:07 PM
Read More
Top Stocks for Today - 5th June 2025

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

5 Jun 2025|07:53 AM
Read More
Gland Pharma gets USFDA approval for blood pressure drug

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

4 Jun 2025|03:34 PM
Read More
Gland Pharma Q4 Net Profit Declines 3.1% to ₹186.5 Crore; Revenue Down 7.3% YoY

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

22 May 2025|08:49 AM
Read More
Gland Pharma Gets USFDA Nod for Glaucoma Drug

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

30 Apr 2025|03:40 PM
Read More
USFDA Issues Three Observations to Gland Pharma's Visakhapatnam Facility

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.

26 Feb 2025|12:22 PM
Read More
Top Stocks for Today - 4th February 2025

Here are some of the stocks that may see significant price movement today: Tata Chemicals, Power Grid, Welspun Enterprises, etc.

4 Feb 2025|07:20 AM
Read More
Gland Pharma Q3 Profit Rises 6.7% YoY

EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortization) increased by 1% YoY to ₹360 crore, compared to ₹356.4 crore in the previous year.

3 Feb 2025|07:43 PM
Read More
Mankind Pharma inks pact to commercialise Sintilimab in India

Sintilimab is marketed in China as TYVYT (sintilimab injectable) and was co-developed by Innovent and Eli Lilly.

27 Dec 2024|09:09 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.